Zopice Tablet — NAFDAC B4-0464: Is It Genuine? Uses, Alerts

产品: Zopice Tablet
NAFDAC编号: B4-0464
活性成分: Zopiclone
强度: 7.5 mg
年级: Tablet
包装规格: 1 x 10's (in Alu-PVC blister)
制造商: 未上榜
申请人（持有人）: Bio-Generics Nigeria Limited
Approved: 24 Jun 2021
Status: Inactive View on NAFDAC ↗
Registration valid to: 23 Jun 2026
WHO提醒: None found
Community reports: None
Times checked: 0

About the medicine: Zopiclone: uses, dosage and brands worldwide

What we found

Zopice Tablet is on the NAFDAC register with an active registration (B4-0464). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

Check your pack of Zopice Tablet

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Zopice Tablet

What is in Zopice Tablet?

Zopice Tablet contains Zopiclone (7.5 mg), as tablet, according to its NAFDAC registration record.

Is Zopice Tablet registered with NAFDAC?

Yes. Zopice Tablet is listed on the NAFDAC register under registration number B4-0464, and its registration is active as of 1 November 2026.

Has Zopice Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Zopice Tablet in our automatically synced alert list.

How can I check that my pack of Zopice Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-0464, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

Patient reviews

–No reviews yet

5★

0

4★

0

3★

0

2★

0

1★

0

Have you used Zopice Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.